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Abstract 
Treatment studies of Localized juvenile periodontitis (LJP) have 
revealed a direct relationship between the elimination of Actinobacillus 
actinomycetemcomitans (A.a.) from the deep pocket epithelium, and disease 
cessation. To evaluate the successful treatment outcome in LJP patients, we 
compared pre and post treatment levels in A.a. in this patient population to 
treatment outcome. Ten LJP patients were randomly divided into two groups, 
with one group receiving antibiotic therapy (a combination of metronidazole and 
amoxicillin) and the other receiving no antibiotic. Both groups received full 
polymorphonuclear leukocyte (PMN) chemotaxis evaluation, microbiologic 
screening, oral hygiene instruction (OHi) and full mouth scaling and root-planing 
(S/RP) prior to surgical therapy. The surgical protocol included open flap 
debridement without resective or regenerative therapy. Using the DNA 
checkerboard method A.a. levels were measured, from samples obtained before 
and after treatment. The findings demonstrate that A.a. serotype b was the 
dominant strain throughout the clinical trial and all the patients n=10 (100%) 
expressed depressed PMN chemotaxis at baseline and at 24-months. The sites 
surgically treated yielded a mean probing depth reduction of 1.48mm (antibiotic) 
and 0.66mm (non-antibiotic) respectively. The treatment groups responded well 
to therapy and there was no statistical difference between both groups. The 
study suggests that LJP cases respond positively to therapy and that the 
judicious use of antibiotic therapy can provide improvement. 
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Introduction 
Localized juvenile periodontitis (LJP) occurs in adolescents and young 
adults, and is characterized by the permanent first molar and incisor bone loss 
(Hormand and Frandsen 1979). LJP lesions are angular bony defects on the 
permanent first molars and the incisors, radiographically seen as arch shaped 
bone loss on the first molars. Periodontal attachment loss, rapid osseous 
destruction and the marked absence of local tissue irritants are key features. 
These observations are often inconsistent with the low levels of supragingival 
plaque, absence of advanced gingival inflammation and a very low caries rate 
(Baer 1971 ). The prevalence of LJP is difficult to estimate, but it is consistently 
reported to be higher in the North American black population at about 2.0 - 2.5% 
(Loe and Brown 1991 ). 
The etiology of LJP is multifactorial. Accumulated evidence has indicated 
that the subgingival microflora comprises Capnocytophaga spp and unidentified 
gram-negative rods (Newman et al. 1976) and (Slots 1976). Later identified as 
Actinobacillus actinomycetemcomitans (A.a.), the organism presently identified 
as the etiological agent in LJP. The evidence supporting A.a. as the etiologic 
agent in LJP is its high prevalence in diseased sites, high titers of serum 
antibodies, expression of potent virulence factors, and the association between 
the elimination of A.a. and healing ( Zambon 1985). Microbiological monitoring of 
the subgingival flora ( especially A.a.) is a critical aid in the successful 
management of the disease, since an effective mode of periodontal therapy can 
be the specific elimination of A.a. infection. 
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The majority of immune functions in LJP subjects appear normal, with the 
exception of depressed polymorphonuclear leukocyte (PMN) response. 
Approximately 70% of subjects have demonstrated depressed chemotaxis to N-
formyl-methionyl-leucyl-phenylalanine (FMLP) and the complement fragment c5a 
(Van Dyke 1980). 
LJP exhibits a low prevalence in general, but a high predilection within 
North American black families. Its high frequency among family members is 
highly indicative of a hereditary component, although no clear genetic basis has 
been established (Risom 1985). The genetic basis for the disease follows 
Mendelian inheritance models, and has been postulated to be an X-linked 
dominant trait, an autosomal recessive or an autosomal dominant trait. Early 
hypotheses supported autosomal recessive, and the X-linked trait. Recent 
studies however, have provided convincing evidence for autosomal dominant 
inheritance (Hart 1992). 
Treatment studies reveal that, without the elimination of A.a. from the 
deep pocket epithelium, it is not possible to successfully treat the disease 
(Christersson et al. 1987). Accordingly, disease management and the 
elimination of A.a. require a combined therapy of scaling and root-planing, 
antibiotic therapy and site specific surgery (Genco 1986). The rationale for the 
use of adjunctive antibiotic therapy is based on the concept that LJP is of 
bacterial etiology, and the eradication of A.a. is not possible without systemic 
medication. However, the inability to eliminate A.a. has not been shown in all 
populations. Currently, the antibiotic therapy used with the greatest efficacy 
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combines metronidazole and amoxicillin. The basis for the use of these drugs 
resides in their broad spectrum and synergistic effects (van Winkelhoff et al. 
1989). 
In this study, we will evaluate the correlation between successful 
treatment outcomes, A.a. presence and antibiotic use. The objectives are to 
determine whether, mechanical therapy and site specific surgery, with or without 
antibiotics, will lead to and a successful treatment outcomes. 
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Literature Review 
Since the early part of the century, periodontal disease has been 
recognized in juveniles and young adults. Gottlieb (1928) described atrophy of 
alveolar bone in young people. The destructive condition with minimal plaque 
and inflammation was termed 'periodontosis' by Orban and Weinman (1942). 
The condition was postulated to represent a degenerative process initiated by an 
unknown systemic condition. The severity and extent of the disease, and the lack 
of a correlation between dental plaque, gingival inflammation and attachment 
loss was particularly important, because it implied a degenerative rather than an 
inflammatory process. 
Butler in 1969 used the term 'juvenile periodontitis' to describe molar and 
incisor bone loss. The author attempted to discard the term 'periodontosis', 
meanwhile alluding to the misuse of the suffix "osis" without concise proof of a 
degenerative process. 
In 1971 Baer returned to the use of 'periodontosis' and suggested a series 
of diagnostic criteria: (i) rapid alveolar bone loss in otherwise healthy 
adolescents, (ii) periodontal destruction not commensurate with local irritants 
and, (iii) involvement of more than one tooth of the permanent dentition. Baer 
also described the generalized form of 'periodontosis'. The generalized form, 
later referred to as Generalized juvenile periodontitis (GJP) as described by Van 
Dyke et al. (1980), is generalized to an arch or the entire dentition. 
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LJP occurring in conjunction with other systemic disease has been 
extensively described in the early literature. Genco, et al. (1986) stratified LJP 
associated with systemic disease into three categories: juvenile periodontitis 
associated with reduced numbers of neutrophils, such as agranulocytosis, cyclic 
neutropenia, Chediak-Higashi syndrome; juvenile periodontitis associated with 
neutrophils of abnormal or compromised function such as Downs syndrome and 
Papillon-Lefevre syndrome, and juvenile periodontitis associated with other 
diseases such as Reticuloendotheliosis, Ehlers-Danlos syndrome and 
hypophosphatasia. The general pattern involving juvenile periodontitis occurs in 
subjects with either primary diseases of neutrophils or diseases in which the 
neutrophils are abnormal. 
The earliest concepts of 'degeneration' defined by Gottlieb (1928) and 
Orban and Weinmann (1942) have been discarded and are no longer held. The 
rapid and advanced destructive profile, in the presence of minimal inflammation, 
and sparse local factors, have remained features accepted in many modern 
definitions of LJP. 
The defining clinical characteristics of early onset periodontitis (EOP), 
were more completely described in the 1989 World Workshop in Periodontics 
1989, since the early studies were hampered by the inability of researchers to 
agree upon specific clinical classifications and subgroups. It has become 
apparent that a clear diagnosis of LJP and GJP is still difficult due to heterogenity 
of clinical and immunologic presentation. The clinical manifestations of LJP may 
have to be reclassified, as new information becomes available. 
5 
The hallmark of LJP is severe angular bony defects in the permanent 
molar region and sometimes-horizontal bone loss on the incisors. Genco et al. 
(1986) defined LJP as a destructive disease, affecting first molars and incisors 
and one or two additional teeth. Loe and Brown (1991) defined LJP as a disease 
in the young in which at least one first molar and at least one incisor or second 
molar and two additional teeth are affected. 
Danly and Ashkenazi (1992) reported typical radiographic findings as arch 
shaped bone loss in the molar region, beginning from the mesial surface of the 
second molar region and extending to the distal of the second premolar. Genco 
et al. (1986) noted a radiographic pattern of bone loss mesial and distal of the 
first molars, not often involving the furcation area. The authors noted that in older 
subjects, the osseous profile is often vertical, and sometimes extends close to 
the periapical region. Both authors, Genco et al. (1986) & Danly and Ashkenazi 
(1992) included bilateral symmetrical patterns of vertical bone loss as a 
radiographic finding. Genco et al. (1986) noted that this presentation is not 
universal. 
Clinically, plaque and calculus deposits are relatively sparse even in the 
areas of the most severe bone loss. Baer (1971) demonstrated that subgingival 
deposits are uncommon even in subjects where the bone loss extends to the root 
apices. LJP subjects generally exhibit very little gingival inflammation as a 
clinical feature, which probably leads to the disease being left undiagnosed in 
many instances. Some cases do, however, demonstrate inflammation of the 
marginal gingiva. Waerhaug (1977) details signs of gingival inflammation in 
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juvenile periodontitis patients associated with sites of destruction. Liljenberg and 
Lindhe (1980) in their histological evaluation of LJP lesions, site the presence of 
a dense infiltrate predominantly of plasma cells and lymphocytes with a variable 
composition of neutrophils and macrophages. 
The progression of bone loss is rapid in LJP. Waerhaug (1977), estimated 
bone loss to be at 4-5µm per day, which is between three and five times faster 
than that observed in adult cases. Gjermo (1986) reported a bone loss rate of 
2mm/per year, whilst (Mandell et al. 1986) sites active destruction as a loss of 
connective tissue attachment of at least 2mm in a thirty-seven day period. 
Burmeister et al. (1984) in an assessment of clinical findings notes that contrary 
to most definitions of LJP, severity of attachment loss was strongly associated 
with plaque and gingival inflammation. 
Yaffe et al. (1993) reports a low caries rate in LJP and the overall . 
negligible subjective symptoms characteristic of disease. In advanced cases, 
Genco et al. (1986) report that incisors may exhibit pathological migration and 
display severe mobility. 
The linear progression from LJP to GJP is uncertain at best. Hormand 
and Frandsen (1979) attempt to make a case for the progression from localized 
to the generalized form with increasing age. Their cross-sectional study reports 
a break-down in the molar incisor area and progression to generalized 
involvement, with more serious bone loss increasing with age, from 12 to 32 
years. 
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The clinical definitions of individual cases, becomes quite complicated 
possibly due to a differing diagnosis for cases which have been followed 
longitudinally. In other words, the same case may be classified as LJP, GJP, 
and RPP if followed over time and diagnosed without historic information. The 
inclusion of LJP as a form of Early Onset Periodontitis (EOP) by the World 
Workshop on Periodontics in 1989 takes into account a high amount of 
heterogeneity. Therefore attempts to categorize LJP into subgroups may be 
inaccurate. 
The clinical diagnosis of LJP is primarily made on the distribution of bone 
loss and the age of onset. Loe and Brown (1991) stated that juvenile periodontitis 
occurs around puberty, and at least until the age of seventeen and possibly into 
the twenties. Sjodin et al. (1989) in a retrospective study, reported that alveolar 
bone loss could be detected in the prepubertal radiographs of primary dentition of 
young subjects who eventually develop LJP. 
The prevalence of juvenile periodontitis varies greatly from author to 
author. Loe and Brown (1991) site that 0.53% of adolescents in the United States 
were estimated to have LJP. Hansen et al. (1984) reported a prevalence of 0.2% 
for Norwegians. Blankenstien et al. (1978) reported 0.06% in-groups of Danish 
and English children. Harley and Floyd (1988) report a prevalence of 0.8% in 12-
19 year olds in Lagos Nigeria. 
Demographic data for LJP is complicated by the interaction of gender and 
race. Loe and Brown (1991) report that blacks were at greater risk for all forms 
of EOP than whites. The authors note that black males were 2.9 times more 
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likely to have LJP as compared to black females, whilst white females were more 
likely than males of the same race to have LJP. 
Brown et al. (1996) reported new findings from the 1991 data survey of 
U.S school children (14,013 adolescents were clinically examined in 1986/1987 
to assess the periodontal attachment loss on teeth) on 91 subjects. Of the 
subjects originally classified at baseline, 62% continued to have LJP at the six-
year mark, and 35% developed GJP. Albandar et al. (1997) studied 265 subjects 
of the original 1986/1987 survey. Results demonstrated that in the LJP disease 
group, one-half of the individuals had moderate/rapid disease progression and 
one-half had slow or no progression of the disease. 
In a review of bacteriological aspects of LJP, a direct relationship between 
disease activity and specific microbiota has been observed. In the mid to late 
seventies, studies by (Socransky, 1977) and (Slots, 1979) revealed that 
periodontal disease is a group of clinical entities with characteristic host immune 
responses and specific microflora. The observation of bacterial specificity 
suggests that periodontal diseases with similar clinical presentation may be, in 
fact, different diseases with a different pathogenesis. 
Newman and Socransky (1977) reported initial findings of gram-negative 
anaerobic rods in periodontosis subjects, and subdivided them into the "five 
periodontosis groups". Morphologic and physiologic criteria are used to define 
the groups. 
Group I: anaerobic saccharolytic vibros 
Group II: organisms include " Capnocytophaga " species 
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Group Ill: tiny gram-negative anaerobic rods (0.3-0.8 µ) 
Group IV: gram-negative saccharolytic Bacteroides-like organisms 
Group V: gram-negative anaerobic surface translocating microorganisms 
with different biological and morphological characteristics from the 
"Capnocytophaga" Group II species. 
Newman et al. (1976), demonstrated in further investigation that the 
microbiota associated with 'periodontosis' was more unique than previously 
thought. Investigations indicated that three major types were present in 
individual subjects. Approximately 13% of studied sites detected only one group 
of gram-negative anaerobic rods, predominately Group 111 and IV or the 
"Capnocytophaga " Group 11 species. 
Cultural studies of LJP the microflora implicated Actinobacillus 
actinomycetemcomitans (A.a.) in the etiology of LJP, by association. Klinger 
(1912) originally isolated this organism from Actinomycotic lesions. Pierce et al. 
(1983) reported the recovery of A.a. from non-oral infections such as bacterial 
endocarditis and from blood cultures. 
Slots et al. (1980) detected A.a. in high numbers from deep pockets of 9 of 
10 juvenile periodontitis (JP) patients, and lower levels of A.a. from 2 of 10 
normal juveniles, 6 of 12 adult periodontitis patients, and 4 of 11 normal subjects. 
Mandell and Socransky (1981 ), isolated A.a. from 6 of 6 JP patients, and 
no A.a. from 23 gingivitis and 25 adult periodontitis subjects. Zambon et al. 
(1983) implicates A.a. as the primary oral bacterium in LJP. A.a. was detected in 
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28 of 29 LJP subjects, and in only 15% of other studied groups (28 of 134 adult 
periodontitis patients and 24 of 142 periodontally healthy subjects). 
Recent observations indicate that not all the tissue destruction in JP is 
associated with A.a. A.a. may cause a large percentage of tissue breakdown, 
but certainly not all. Moore (1978), in a review of longitudinal data, reports that 
that the concentration of A.a. in 43 active sites was 0-1 % in approximately 37% 
of sites, 1-10% in 60% of the active sites, and 74% in 2% of the sites. In the 
same patients, 98% had 0.3% or less A.a. Savitt and Socransky (1984) reported 
that the concentration and incidence of other species equaled or exceeded the 
levels of A.a. in affected sites in J.P patients. In 12 J.P patients A.a. comprised 
4.8% of the flora. F. Nucleatum and small spirochetes were found in 90% of 
sites. 
Haffajee et al. (1985) reported that a concentration of 0.3% A.a. was 
present in active sites of subjects that responded well to therapy and the same 
concentrations were present in poor responders. The data is suggestive of the 
pathogenic influence of other species. 
Lopez et al. (1996) using DNA probes reported on the occurrence 
of Porphyromonas gingivalis (P.g.), and Prevotella intermedia (P.i.) in juvenile 
periodontitis subjects. The investigators reported finding A.a., P.i. and P.g. in 8 
of 32 diseased sites. The combination of P.g. and P.i. without A.a. was found in 
19 of 36 LJP diseased sites. The data is indicative of a proportion of LJP, which 
do not carry detectable levels of. A.a., or could be more frequently associated 
with P.g. and P.i. From data available from current studies Williams et al. (1985) 
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proposed that, it is plausible that episodes of periodontal destruction might be 
consecutive assaults by different species. The importance of other 
microorganisms cannot be understated, but evidence based data suggests that 
A.a is the most important microbe in the etiology of LJP. The biochemical, 
morphological and serological characteristics of A.a., magnify its importance as a 
virulent periopathogen. 
King and Tatum (1962) in investigations conducted showed 3 serogroups 
of non-oral A.a. on the basis of a heat stable component. Zambon et al. (1983) 
reported on the distribution of biotypes and serotypes within families. The study 
revealed that A.a. was present in 15% of adult periodontitis, periodontally healthy 
and insulin dependent diabetes with varying degrees of gingivitis. Serotypes a 
and b were equal in prevalence in periodontally healthy subjects, but serotype b 
was increased in LJP, implicating this antigen in the pathogenesis of the disease. 
The serotype differences between native populations have been 
extensively studied, Chung et al. (1989) utilizing immunofluorescence and Elisa 
reported on serotype findings in the Korean population. Results reveal equal 
distributions of serotypes a, b, and c in Korean LJP patients. LJP subjects from 
the United States have previously exhibited a two-fold higher frequency of 
serotype b than a and c combined. This data may be indicative of genetic and 
environmental differences, rather than virulence. 
A.a. fulfills the four criteria for gram-negative pathogenicity, as detailed by 
Smith in (1975). The ability to (I) attach to host tissues, (II) grow and multiply in 
the host's environment, (Ill) evade host defenses and (IV) the capability of 
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damaging host tissues. Holt et al. (1980) report A.a. bacterial cells as non-motile 
cocci which measure 0.7±0.1 µ by 1.0 ±0.4µ occurring singly, in pairs or in 
clumps. The author described A.a. as gram-negative in nature, with an outer 
cytoplasmic membrane, periplasmic space, and an inner cytoplasmic membrane. 
In 1982 Slots, in a detailed study, demonstrated A.a to be fermentative, 
non-hemolytic, indole negative, and catalyse producing. The microbe is 
distinguishable from other similar bacteria, such as the Haemophilus species, by 
its ability to grow in the absence of V (nicotinamide adenine dinucleotide) or X 
(hemin) growth factors. 
Pulverer and Ko (1970) report on the use of carbohydrate fermentation to 
subgroup into biotypes. The organism categorized into 10 biotypes, based on 
the variable fermentation of sugars, including galactose, maltose, xylose, dextrin 
and mannitol. 
The etio-pathogenicity of LJP is complicated by the ability of A.a. to 
penetrate the deep gingival tissues. The ability of A.a. to penetrate the cultured 
epithelial cell may be coordinated by the regulation of genes involved in the 
rough to smooth A.a. phenotypic transitions. Mayer et al. (1991 ), link the ability 
of the proficient smooth A.a. to penetrate, to the possibility of it playing a role in 
the episodic nature of periodontal disease. A.a.'s invasive characteristics are 
further described by Sreenivasan et al. (1993), as a cyctochalasin D and 
cyclohexidine-sensitive process. The inhibition of bacterial protein synthesis was 
shown to decrease invasion, with no significant role of eukaryotic endosomal 
acidification in A.a. invasion. 
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Zambon (1985) reports on the role of the A.a virulence factor leukotoxin. 
A.a. leukotoxin is described as a protein sensitive product, which lyses human 
polymorphonuclear leukocytes (PM N's), the neutrophil-like promyelocytic HL-60 
cell line human monocytes. Tsai et al. (1981 ), revealed that sera from juvenile 
periodontitis subjects, at levels greater than 90%, contain antibodies which 
neutralize A.a. leukotoxin. The leukotoxin reaction in serum from normal patients 
and those with other types of periodontal disease usually amplified rather than 
inhibited the reaction. Zambon et al. (1983) cites this reaction as indicative of the 
presence of antibodies to leukotoxin in LJP and the protective nature of the 
antibody response. Listgarten et al. (1981 ), who associated mean levels of A.a. 
in JP, chronic periodontitis and periodontitis free subjects. A critical feature was 
the absence of a significant difference between group titers. These authors, 
noted wide variations in antibody titers in individual subjects, possibly negating 
the use of antibody titers as a primary diagnostic test for LJP. 
The role of leukotoxin from A.a. in periodontally healthy and diseased 
subjects, has become a major focal point for research. Zambon et al. (1983) 
reported that 16% of A.a. from healthy subjects were leukotoxin producing, 
compared to 55% of LJP patient isolates. The same patients also harbored both 
leukotoxin producing and non-producing isolates. Slots et al. (1982) assessed 
the molecular basis for A.a. leukotoxin action. Results demonstrated high levels 
A.a. present in LJP lesions and large amounts of A.a. leukotoxin at diseased 
sites. The leukotoxin may restrict local host defense mechanisms by destroying 
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high levels of PMN's, while exacerbating local tissue destruction with the release 
of hydrolytic enzymes. 
Bueno et al. (1998) recently detailed a relationship between the 
conversion of LJP susceptible children from health to disease, and the role-
played by A.a. leukotoxin. The authors note that a deletion in the leukotoxin 
promoter region (of the leukotoxin gene operon) is associated with the 
conversion from health to disease status, and indicative of a high level 
expression leukotoxin genotype. This study also re-identified a statistical 
correlation between leukotoxin-producing genotype and LJP in the African-
American population. 
Schenkein in a critical analysis of the Bueno paper highlights three key 
ideas in the etiology of LJP; 
(i) A.a. contains highly toxic strains, more commonly present in 
healthy pre-pubertal children who later develop LJP, than less toxic 
strains. 
(ii) Certain clonal types of A.a. are causitive agents in the initiation of 
the LJP disease state. 
(iii) Microbiological testing may be specific but inadequate. Elevated 
levels of A.a., may not correlate to levels of pathogenic clonal 
types, leading to false positive results. 
A key virulence factor produced by A.a., which can directly cause tissue 
destruction, is lipopolysaccharide (LPS). Kiley and Holt (1980) reported findings 
on the characterization of LPS from A.a. LPS from A.a. contains Lipid A, an inner 
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core of 2-keto-3-deoxyoctonate and heptose, and outer carbohydrate region 
consisting of galactose, galactosamine, glucosamine, fructose and rhamnose. 
LPS from A.a. has the ability to secrete and synthesize the cytokines interleukin-
1 (IL-1) and Tumor necrosis factor-alpha (TNF-a), hydroytic enzymes and 
prostaglandins, especially PGE 2. 
TNF-a, IL-1 alpha, and IL-beta are potent monokines that mediate 
inflammation and the resorption of bone. Saglie et al. (1990) reported LPS 
stimulation of macrophages by A.a. At low concentrations LPS from A.a. 
stimulated human macrophages dramatically increasing the accumulation of 
mRNA coding for IL-1a, IL-1 ~, and TNFa. The protein level of TNFa and IL-1 
are also increased. The levels of mRNA's in stimulated macrophages increase 
4-5 fold, compared to unstimulated macrophages. 
Shapira et al. (1994) reported findings of a similar nature utilizing adherent 
mononuclear cells (AMNC), instead of macrophages, from LJP and severe 
generalized periodontitis. LPS stimulation resulted in the dose dependent 
secretion of significantly higher levels of PGE2 by LJP AMNC compared to the 
severe generalized periodontitis group. 
Current data demonstrates that the significant histiopathic characteristic of 
LJP, distinguishing it from other forms of periodontitis, is extensive loss of 
collagen from the gingival connective tissue. 
Gillet and Johnson (1982) described a profound loss of collagen from the 
plasma cell dominated gingival connective tissue. The saliva of LJP subjects 
exhibits low amounts of collagenase compared with the saliva of adult 
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periodontitis subjects. lngman et al. (1993) describes the salivary collagenase of 
LJP, insensitive at 1 00mµmol/1 and inhibited at 600mµmol/1 doxycycline 
indicative of the role of matrix metalloprotinase-1 (fibroblast type1 enzyme). 
Current data suggests collagenase release from the PMN's from juvenile 
periodontitis subjects. Suomalainen et al. (1991) report the abnormally 
functioning PMN's in JP patients may result in the colonization of bacteria that 
activate resident periodontal cells to produce collagenase. 
The pronounced systemic antibody response to A.a. found in most LJP 
patients is clearly due to humoral antibody responses to periodontal bacteria. 
Increased concentrations of serum lgM, lgA, lgG, and phytohaemagglutinin 
(PHA) to certain bacteria have been described in juvenile periodontitis patients 
by Lehner et al. 1974. 
Subsequent researchers have conducted investigations into the clinical, 
immunologic and microbiologic features in juvenile periodontitis. Genco et al. 
(1980) examined the precipitating antibodies to sonicates of A.a. Demonstrating 
their elevated presence in the sera of LJP subjects. Ebersole et al. (1982) 
reports on findings of human serum antibody responses to A.a. Ninety percent 
(90%) of LJP subjects studied demonstrated increased levels of anti-A 
actinomycetemcomitans serotype b lgG antibody. 
In an attempt to define the etiology and pathogenesis of LJP, it has 
become necessary to characterize the major antigen(s), of A.a. recognized by 
antibodies in the sera of patients. Simms et al. (1991) described the 
immunodominant antigen class of A.a. as a non-protein serospecific material that 
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is present in the purified A.a. fraction. Wilson and Schifferle (1991) demonstrated 
evidence associating A.a. serotype b, and lipopolysaccharide (LPS). They note 
that a specific determinant of serotype b resides in the polysaccharide side chain 
of LPS. The serotype b antigen and the polysaccharide moiety of LPS, are also 
shown to be immunochemically identical. 
Frequently, in studies of LJP, the immunoglobulin (lg) classes are 
elevated, and the A.a. serotype bis elevated, and isolated. It is therefore 
important to elucidate the immunodominant antigens of A.a. serotype b (Aab ), for 
different lg classes. Evidence for this relationship, has been detailed by Lu et al. 
(1993). Carbohydrate smeared antigen was immunodominant for lgG, lgA, 
lgM,lgG1 ,lg G2, lgG3,lgA 1 and lgA2. LPS elicited the highest antibody level, and 
the most reactive lg's and lgA 1. 
Brown et al. (1991) provided further evidence, for the relationship between 
lgA antibodies, and A.a. in JP. Sera from JP subjects indicates the presence of 
both lgA2 antibodies before and after treatment, (surgical debridement with 
adjunctive tetracycline 250mg q.i.d for three weeks), with the lgA1 antibodies 
present in the highest distribution. 
The next logical step in the diagnosis and classification of LJP would be to 
link immunological data and circulating serum antibodies with the clinical 
expression of disease. The relationship between precipitating serum antibody to 
A.a. and attachment loss was conducted by Ranney et al. (1981 ). In the sera of 
77% of LJP subjects precipitating antibody was demonstrated. Approximately 
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80% of the reactions were associated with the serotype b (Y 4 strain). Detectable 
antibody was also associated with a lower percentage of involved teeth. 
Gunsolley et al. (1987) and Tineo et al. (1997) explored the relationship, 
between antibody response and attachment loss. The former report initial 
findings between antibody reactivity and attachment level patterns. A significant 
inverse relationship is described between Haemophilus actinomycetemcomitans 
(H.a.) Y4, and Bacteroides gingiva/is (B.g.). A correlation is made between the 
number of teeth having a slight or moderate and moderate or severe attachment 
loss. The absence of a significant correlation between autologous strains of A.a. 
to lgG antibody titers, and clinical attachment loss in LJP subjects, is described 
by Tinoco et al. (1997). Study findings demonstrate a weak overall correlation to 
attachment levels; low lgG serum responders had more moderately affected 
teeth than the high responders and undetectable levels of A.a. 
The disproportionate distribution of LJP to the black segment of the 
population, has logically initiated study into the effect of racial differences, 
periodontal status and reactive antibody to A.a. The serum antibody reactivity to 
A.a. Y 4 strain in black versus white subjects, is detailed by Gunsolley et al. 
(1988). Initial findings demonstrate a higher prevalence of A.a. serotype b (Y4 
strain) in black subjects as opposed to their white counterparts. White non-
periodontitis subjects, previously used as controls, displayed a significantly lower 
frequency of A.a. Y 4 seropositivity than black non-periodontitis counterparts. 
These findings substantiate the need for race matched controls in antibody 
studies to A.a. 
19 
Smoking, is believed to cause systemic effects on inflammatory and 
immune responses. Tangada et al. (1997), assessed smoking levels by 
monitoring cotinine levels (stable metabolite of nicotine, measured using a 
double antibody radioimmunoassay) in Generalized Early Onset Periodontitis (G-
EOP) and LJP subjects. Smoking was not correlated with a reduction in serum 
lgG2 and anti-A.a. in LJP smokers, but conversely was associated with a 
dramatic rise in G-EOP smokers. 
In-keeping with the recognition of specific Mendelian hereditary patterns 
amongst family members, researchers have sought to define the immunological 
profile of subjects within family groups with a high prevalence of JP. Vandesteen 
et al. (1984 ), reported findings from a proband of a 19-year-old white female 
subject with rapidly progressive periodontitis (RPP), six siblings diagnosed with 
JP and both parents edentulous since early adulthood. Neither, A.a. species nor 
antibodies specific for any of the three serotypes were detected. Antibody to 
Porphomonas gingiva/is (P.g.) and Porphomonas intermedia (P.i.) were detected 
in five of seven family members. Consequently, these results demonstrate that 
A.a. doesn't universally dominate the pocket flora of all JP subjects. 
The microflora and immunologic profiles of JP are very complex, even 
amongst probands that are initially affected by parents with JP. Page et al. 
(1985) reported findings from a family with both parents diagnosed as JP and 
having two affected and two unaffected children. The microflora is identified as 
antibodies specific for A.a., Hemophi/us aphrophilus and Eikenella corrodens in 
the serum of the affected children. Capnocytophaga sputigena and C. ochracea 
20 
in the father, no antibodies of the studied species were present in the mother or 
the unaffected child. 
The early investigations of individuals with LJP led to the observation that 
a large percentage of the patient population, demonstrate a defect in the PMN's 
ability to respond to chemotactic agents in a chemotaxis bioassay Giancola et al. 
(1977). 
Clark et al. (1977) confirmed this observation, suggesting that depressed 
neutrophil function may initiate the mechanism of periodontal destruction through 
two mechanisms. The altering of the matrix of connective tissue and epithelial 
components with the release of toxic metabolites, accelerating tissue destruction, 
by the inability of defective neutrophils to protect the host from periodontopathic 
microbes. 
Examination of abnormal neutrophil chemotaxis by additional researchers 
enhanced the observation that abnormal activity among this cell is suggestive of 
failure of the host's protective mechanism, and leads to an increase in 
periodontal disease. 
Lavin et al. (1979) reported findings of modest leukotactic defects in 86% 
of JP patients, which the authors attributed to intrinsic abnormality of the cells. 
Ellegard et al. (1984 ), in a comparative study between juvenile periodontitis 
patients and adult patients with advanced disease, concludes that the neutrophil 
defect is not as a result of defective mobilization of energy in the neutrophils 
during active movements. The adult subjects with advancing · disease, . did not 
display defective chemotaxis, thus the chemotactic defect was summarized as 
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not being a universal prerequisite for continuing attachment loss. Page et al. 
(1984 ), reported findings which extend the concept that the abnormality exhibited 
by periodontitis patients may not be attributed to unresponsiveness, but is a 
result of enhancement of cyclic variation of the body's neutrophils. 
Van Dyke et al. (1981 ), in the detailed examination of neutrophils from 
subjects with impaired function, has yielded data on the deficiency of surface 
receptors and complement fragments. Van Dyke et al. (1982), reported findings 
that LJP depressed neutrophils have a deficiency in surface receptors for 
chemotactic agents, such as formyl peptides (N-formyl-I-methionyl-l-leucyl-
phenyl-alanine FMLP) and complement chemotactic factor C5a. The selective 
depletion of cell surface glycoprotein of 11 0,000Mr (GP110), at an approximate 
40% reduction was also explored by (Van Dyke et al. 1987). The data from this 
study pointed to the use of GP110 as a possible disease marker in LJP. 
Abnormalities in the cell surface of the PMN have been rigorously 
explored in the LJP-associated reduced chemotaxis. 
De Nardin et al. (1990), in study data, demonstrated altered reactivity of 
monoclonal antibodies to FMLP in LJP-defective neutrophils. Daniel et al. (1993) 
explored abnormalities in signal transduction. In investigations conducted, the 
authors report abnormalities in signal transduction with a resultant decrease in 
extracellular calcium. 
Neutrophils from LJP patients exhibit chemotactic defects to a variety of 
chemotractants, and defects in phagocytosis. Cogan et al. (1986) reported 
findings of defects in phagocytosis in JP to S.aureus and Candida albicans. 
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Kalmar et al. ( 1987) described a defect in the bactericidal activity towards A.a. 
that is exposed as a defective phagosome-lysosome fusion following 
phagocytosis. 
The relationship between race, and chemotactic response in the JP 
population has yielded significant data. Van Dyke et al. (1985) describes the 
presence of a demonstrable chemotactic defect in approximately 70% of the LJP 
population. The racial distribution of the study population in this study and 
numerous others quantitatively indicates a black racial predilection. Schenkein et 
al. (1991) in a study on the influence of race on periodontal disease status and 
neutrophil response, demonstrate that the neutrophils from periodontally healthy 
black patients are less responsive than those from white subjects. The 
chemotaxis responses between healthy subjects were significantly different. The 
results indicate that the overall prevalence of a lowered chemotactic response in 
the black study population, may have been overestimated, in the absence of the 
use of race matched controls. 
The nature of the chemotactic defect is yet to be determined, whether the 
dysfunction is intrinsic to the cell itself, or acquired by the cell following exposure 
to various bacterial agents. Baker et al. (1989) in initial study findings proposed 
the data supportive of the intrinsic theory, suggest that normal cells from sera of 
LJP subjects cannot be induced to produce a chemotactic defect. Key evidence 
for the 'intrinsic' defect is also introduced by Lavine et. al. (1979) in initial study 
findings. The authors demonstrated that periodontal therapy doesn't eliminate 
the defect, thus indicating the inability of the infection to regulate the defect. Van 
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Dyke et al. (1985) presented findings of a depressed neutrophil chemotaxis 
among all the siblings in which the proband exhibits a defective neutrophil 
disorder. The data is consistent with an intrinsic disorder. 
The evidence of the acquired defect is mainly associated with the passage 
of infectious agent's (A.a.) into the host, or the family subunit and the consequent 
exposure to virulent cytokines. Agarwal et al. (1991) in initial findings, proposed 
that the production of disease desensitizing cytokines are as a result of the 
leukocytes' response to infection and the subsequent depreciation in the activity 
of the neutrophils. Van Dyke et al. (1982) in study findings revealed that 
periodontal bacteria, induce defects 'in vitro', suggesting that 'in vitro' chemotaxis 
was mediated by non-chemotactic components. This observation is consistent 
with a link between the overwhelming effect of bacterial byproducts and acquired 
disease. 
The correlation between human leukocyte antigens HLA, which regulate 
the immune process, has been suggested. Kaslick et al. ( 1975) demonstrated no 
correlation between HLA-A2 and LJP. Saxen and Koskimies (1984) also failed to 
correlate a relationship between the JP gene and HLA antigens, even after tissue 
typing for HLA A, B, and C locus antigens, and two families for the Dr locus. In a 
dissenting opinion, Firatli et al. (1996), found HLA-A24 and DR4 were 
significantly higher in JP than in controls. This is indicative of a role for the HLA 
antigens, and evidence for increased risk of susceptibility for disease. 
The higher frequency of the occurrence of the LJP in family units has led 
researchers to attempt to establish a linear Mendenlian trait associated with the 
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disease. The aggregation of the disease within families alludes to genetic 
mechanisms, apart from the bacterial etiopathogenesis. Schenkein and Van 
Dyke (1994) alluded to hypotheses, which include both etiologies: genetic or 
bacterial. The authors note the activity of pathogenic plaque may be enhanced or 
decreased by inactive or defective genes. 
A number of genetic inheritance models have been proposed for LJP. The 
autosomal recessive pattern was most frequently suggested due to the general 
family pattern. Subsequent familial studies however, have failed to reach a 
conclusion on the mode(s) of inheritance. Saxen and Nevanlinna (1984) made 
observations in the support of the autosomal recessive model, as parents were 
either infrequently, or not affected by the disease. The diagnostic certainty of the 
parent's disease status has however brought this theory into question. Risom et 
al. (1985) reported on studies consistent with X-linked transmission, based on 
increased prevalence among females. The author reported on a family consisting 
of an affected mother and four affected offspring, with the offspring having 
different fathers. 
Recent data however suggests that a female preponderance may be due 
to acertation bias. Hart et al. ( 1991 ), reported that for affected family members 
other probands equal preponderance of females and males were found. 
More recently, with complex segregational analysis has been used to 
outline arguments for autosomal dominant patterns of LJP. Marazita et al. (1994) 
reported findings segregational analysis of EOP in 100 families. The dominant 
mode of transmission was theorized with a penetrance of approximately 70%. 
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Linkage analysis has been utilized to determine the mode of inheritance 
when candidate loci or Mendelian markers have been recognized. Boughman et 
al. (1986) provided additional data for the autosomal dominant mode of disease 
of transmission; the authors report findings on a family with both dentinogenesis 
imperfecta and LJP, with a genetic linkage for both diseases on chromosome 4. 
Hart et al. (1993) were far less conclusive in the evaluation of this data, in 
EOP families, (35 LJP) without dentinogenesis imperfecta. They propose that the 
linkage was either a false positive, or there are two or more unlinked forms of 
EOP. 
The controversy ever present in the patho-etiology of LJP is as a 
result of great deal of heterogeneity in disease presentation. Treatment studies 
of LJP have revealed that without the elimination of A.a. from the deep pocket 
epithelium, it is not possible to treat the disease successfully. Scaling and root 
planing alone has not proven sufficient to eliminate A.a. from the deep pocket 
epithelium, gingival connective tissue and alveolar bone. Saxen et al. (1990), in 
initial studies, demonstrated that the rationale for adjunct antibiotic therapy is 
based on the concept that LJP is of bacterial etiology, and the eradication of A.a. 
is not possible without systemic medication. However, the inability to eliminate 
A.a. has not been demonstrated in all populations. Notably, Wennstrom et al. 
(1986) demonstrated successful treatment of LJP (including A.a. elimination) in 
the absence of mechanical therapy. 
Recent studies have employed the use of different therapies and dosages 
of antibiotics. The medications that have been emphasized are tetracycline, 
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doxycycline (semi-synthetic tetracycline derivative), metronidazole and 
amoxicillin. Slots and Rosling (1983) reported the use of tetracycline's in treating 
LJP to be promising. Tetracycline is bacteriostatic, and has an inhibitory effect 
on collagenase activity in crevicular fluid and inflammatory cells. The authors 
observed decreasing pocket depths and increased attachment levels, but 
tetracycline was unable to completely eliminate A.a. from disease sites without 
adjunctive therapy. Novak et al. (1988) and (1991) assessed the use of 
tetracycline alone (without mechanical debridement) and reported a 72% fill of 
angular bony defects and a mean decrease in attachment loss. These studies 
however, lack microbiological data analyses. 
The effect of doxycycline in the suppression of A.a. has been proven to be 
less than originally believed. Mandell and Socransky (1988) demonstrated that 
doxycycline and mechanical therapy have shown to be better than doxycycline 
alone, but the drug has failed to arrest disease activity both over the short and 
long term. 
van Winkelhoff et al. (1989), conducted a study on the efficacy of the 
metronidazole and amoxicillin combination. The basis for the use of these drugs 
points to their bacterial action, broad spectrum and synergistic effects. In a 
subsequent study van Winkelhoff et al. (1992) also demonstrated the ability of 
this drug combination to suppress A.a. below detectable levels with significant 
gains in mean clinical attachment, bleeding index and pocket depth reduction. 
Pavicic et al. (1991) and (1992) with 'in vitro' studies, demonstrated the 
synergistic effects of metronidazole and amoxicillin against A.a. and the 
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comparison to the drugs' 'in vivo' efficacy. The investigators utilized the 
checkerboard technique, showing synergism against A.a. by metronidazole and 
its hydroxymetabolite. 
Controversy exists with regard to the most appropriate way to treat LJP 
lesions surgically. A surgical triad exists for the treatment, of LJP. It includes; 
I. Guided tissue regeneration (GTR)-with/without bone grafting 
11. Open surgical debridement-with/without osseous resection 
Ill. Osseous resective surgery-pocket elimination. 
Yukna and Sepe (1982), reported on the use of freeze dried bone allograft 
(DFDBA) in combination with tetracycline. They reported 35% of sites to be 
completely filled and > 50% fill in 98%. 
Di Battista et al. (1995) investigated the effectiveness of surgical 
debridement versus various GTR techniques. Results demonstrated no statistical 
differences among tested modalities and surgical debridement alone in LJP. 
Sirirat et al. (1996), compared osseous surgery and GTR. Both techniques were 
shown to regenerate new clinical attachment, although gain was more significant 
in the GTR gro.up's (2.20 ± 1.42mm). 
The predominant thought exists that extensive healing is possible after 
treatment in LJP cases. Numerous investigators have reported that after 
treatment, there is gain in clinical attachment and re-fill of bone in angular bony 
defects. Talonpoika (1992), reported that after scaling, curettage and modified 
Widman Flap, bone loss was 10.1 % less than prior to treatment. The author 
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suggests periodic recalls lasting at least one year as necessary to evaluate the 
efficacy of treatment in JP cases. 
Dubrez et al. (1996), in a case report, demonstrated that following 
subgingival instrumentation and high-resolution radiographs, there was 
considerable improvement after one year. Bone density was high up to 1.5 years 
post treatment. However five of eight sites lost density and the authors attribute 
this to continuous remodeling, variations in inflammation, and the aggressive 
nature of certain lesions. 
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Methods and Materials 
I. Patient selection 
The study was designed as a randomized controlled clinical trial and 
approved by the Institution Review Board (IRB). The study population of 
Localized juvenile periodontitis (LJP) subjects was obtained through referrals 
from community health centers and private dental offices in the Boston 
Metropolitan area. The subject selection was based on the 1989 World 
Workshop in Periodontics (1989). Subjects were restricted by age range to a 
minimum age of 11 (pre-pubertal onset) and a maximum of age 21. Clinical and 
radiographic profiles featured severe angular bony defects in the permanent 
molar region, and sometimes-horizontal bone loss in the incisors. All the cases 
selected, demonstrated the classic LJP features of minimal hard and soft tissue 
deposits with the absence of gingival inflammation, regardless of the underlying 
osseous profile. The study was initiated with 10 LJP patients, age's 14-21 years 
old. One patient dropped out after the treatment and recall, phase would not 
return for final post-treatment microbiological monitoring, and could not be 
included in any analysis of the final study data. Four of the nine were referred 
from area health centers and the remaining 5 from private practices in the Boston 
area. Three (3) patients were female, and six (6) males. The antibiotic group 
consisted of two (2) females and two (2) males, whilst the non-antibiotic group 
consisted of one (1) female and four (4) males. The study group consisted of 
eight (8) blacks of varying ethnic heritage and one white Hispanic. The study 
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subjects' diagnoses were reviewed and thoroughly authenticated prior to 
enrollment in the clinical trial. Medical histories were thoroughly checked, with 
exclusion criteria being: systemic disease, antibiotic usage within 6 months, and 
tobacco use. Study subjects' baseline data collection included full mouth 
radiographs (Figs.1 and 2), venous blood and plaque samples, and periodontal 
indices initially obtained prior to enrollment in the treatment phase of the study. 
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Figure 1 Full mouth radiographs of a 14 year-old male LJP patient. Note 
the angular bony defects at all four molars (#'s 3, 14, 19, 30). Bone loss is 
also visible at the maxillary incisors. This is the classic LJP presentation. 
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Figure 2 Full mouth radiographs of an 11-year-old male LJP patient. 
Note the angular bony defect at the lower left first molar (#19). Slight 
alteration of the bony architecture is noted at the mesial of the maxillary 
left first molar (#14 ). 
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Subsequently, subjects were randomly enrolled in the mechanical and antibiotic 
phase of therapy, prior to site specific surgical therapy, for all sites. The subjects 
were then clinically monitored in three-month intervals, for a 24-month period. 
II. Isolation of PMN and chemotaxis assay 
The patients diagnosed with LJP were compared to a control group 
consisting of 9 healthy individuals from the dental school and laboratory 
populations, who had no radiographic evidence of bone loss or periodontal 
disease. The general health of patients and controls was determined by a 
comprehensive health questionnaire, no participants with systemic disease, or in 
poor general health were included. Patients and controls were age, race and sex 
matched for all experiments. 
PMN's were isolated from peripheral venous blood utilizing ficoll-Hypaque 
centrifugation. Monopoly Resolving Medium (M-PRM) (Flow laboratories Inc, 
Mclean,Va) is mixed well, immediately to use, inverting 2-3 times. 
Subsequently, 3ml of M-PRM is placed in a sterile 15ml centrifuge tube and 
carefully overlayed with 1 ml of Histopaque 1077 (Sigma Diagnostics). The 
mixture is carefully layered with 3.5ml of fresh, heparinized, human blood 
(volume of blood can be increased to 7 .5ml). The maximum separation and 
functionality can be obtained in cells that have been separated within 2 hours of 
collection. The solution is centrifuged at 1200 RPM for 30 minutes in a swing 
bucket rotor at room temperature. Some blood samples may not separate 
initially, and continued spinning may be necessary for 15-30 minutes. Three 
fractions should be obtained when blood is separated with M-RPM and 
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Histopaque 1077: (i) FR-1 ( at plasma interface):MN band or mononuclear 
leukocyte band; (ii) FR-2 (below the interface): PMN band; (iii) FR-3: Red blood 
cell pellets. Using a sterile Pasteur pipette gently lower the tip to the FR-2 layer, 
withdraw and transfer the PMN band to 50ml centrifuge tube. The cells are 
washed once with Phosphate buffer saline (PBS), if red blood cells (RBC's) are 
present, add 10 ml of cold lysing buffer, gently re-suspend cells and allow the 
solution to stand for 6 minutes on ice. PBS is added to bring the solution up to 
50ml. The mixture is centrifuged at 900 RPM for 10 minutes at room 
temperature, the supernatant poured off and 10ml of PBS added, then the cells 
are re-suspended for counting. 
Chemotaxis was measured using a modified Boyden chamber as 
described by Snyderman et al. (1986). Cell suspensions were >99% viable and 
>95% PMN as tested by tryphan blue exclusion. The chemotactic agent was the 
chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) (Peninsula 
laboratories, San Carlos, CA). The assay was conducted as follows: a cellulose 
nitrate filter 5µm pore size, 13Mm in diameter, and 140µm thick (Sartorius-
membranfilter GMBH, Gottingen, G.F.R.), was placed between two chamber 
compartments of a modified Boyden chamber. The upper chamber contained 
0.4ml of cell suspension. The lower compartment of each chamber contained 
0.8ml of chemotactic factor or Gey's/GVB2+ solution alone. 
The chambers were then incubated in 5% CO2/95% air atmosphere at 
37°C in a humidified incubator for two hours. Following incubation, the filters 
were gently removed from the chamber (avoiding aspiration of fluids) and fixed in 
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methanol and 4% neutral buffered formalin for at least 1 0 minutes. The filters 
were then stained with Mayer's hemotoxylin, and dehydrated sequentially with 
70%, 95% and absolute alcohol for 2 minutes each, followed by isopropanol for 4 
minutes. The filters were immediately cleared in xylene and mounted on glass 
slides. The isopropanol and absolute alcohol used in the dehydrating steps were 
kept anhydrous by the addition of 1 vol. of Molecular Sieve (Linde Division, Union 
Carbide, Niagra Falls, NY) to 10 vol. of alcohol. The results were determined by 
(1) the 'leading front' technique (Zigmond and Hirch 1973), (2) enumeration of 
cells on the distal surface of the filter, and (3) counting cells at predetermined 
levels through the filter. 
The chemotactic response was evaluated at the baseline and study 
completion and found to be depressed among all 9 of the enrolled patients. 
Chemotaxis was re-evaluated at 24-months, at the study completion. 
Ill. DNA-DNA hybridization "Checkerboard" 
The microbiota associated with LJP has consistently implicated A.a. as the 
etiologic agent with an overlay infection of Porphomonas gingivalis (P.g.) (Slots 
et al 1980). The relationship between A.a. and LJP has been firmly established. 
In this clinical trial, an effort was made to quantitatively and qualitatively 
determine the relationship between bacterial species and LJP. The 
checkerboard technique allows the simultaneous determination of the presence 
of multiple bacterial species in single plaque samples. 
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IV. Plaque samples 
Gracey 11-12 periodontal curettes were used to remove subgingival 
plaque deposits from the periodontal pocket. Samples were placed in 150µL of 
TE (10Mm Tris-HCL, 1 Mm EDTA, pH 7.6), 150µL of 0.5M NaOH was added and 
the suspension boiled for 5 minutes. 
The solution was allowed to cool, 800µL of 5M ammonium acetate was 
added to each tube and then pipetted into the extended slots of the Minislot 
apparatus, with a nylon membrane (Boehringer, Mannheim) mounted. The 
solution was aspirated by vacuum and DNA deposited on the membrane surface 
fixed by exposure for 30 seconds by an ultraviolet light source. Hybridizations 
were carried out in a Miniblotter 28 with digoxigenin- labeled whole genomic 
probes. 
The membranes were then removed from the Miniblotter and washed for 5 
minutes, 4 times each in 1XSSC. The membranes were then incubated for 5 
minutes in 100mM Tris-HCL, 100 Mm NaCl, and 50 mM MgC'2at pH 9.5. The 
probes now bound, were detected by chemiluminescence (exposure times 1-3h 
at 37°C). 
V. Purified Bacterial DNA 
DNA was isolated from reference and fresh isolates and related species, 
then quantified using a spectroflurimeter and Hoechst 33258 dye. Each DNA 
sample was adjusted to 1 ug/µL and loaded into the channels of a Miniblotter 45 
(lmmunetics, Cambridge MA). The membranes were incubated at 4°C overnight 
resulting in the deposition of approximately 1 ng DNA per mm2 on the surface of 
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Hybond-N and nylon membranes (Amersham, Arlington Heights, IL, USA). The 
membranes were removed from the device and the DNA denatured and fixed in 
a solution of 0.4M NaOH and 1.5ml NaCL. After fixation, the membranes were 
pre-hybridized at 42°C for 1 h in 50ml of 50% formamide, 5Xssc, 1 % casein, 5x 
Denhardt's solution (1 x=0.20% ficoll,0.02% polyvinylpyrrolidone, 0.02 bovine 
serum albumin), 25mM sodium phosphate (pH 6.5) and 0.5 mg/ml denatured 
herring sperm DNA. 
The membrane was then placed in the Miniblotter 45, rotated 90° from its 
original orientation. Digoxigenin - labeled whole chromosome DNA probes were 
prepared from each of the test strains using a random primer technique. 
The probes and hybridization buffer were combined and injected into 
individual lanes in the Miniblotter. Each lane contained 130µL of hydridizing 
solution. 
Membranes were hybridized with gentle shaking overnight at 42°C. In an 
effort to detect hydrids, membranes were blocked with 1 % casein in maleate 
buffer (1 00Mm maleic buffer). Following washing, the membranes were 
incubated for 1 h at 37°C IN 4 -methoxy-4- (3 -phosphatephenyl) - spiro (1,2-
dioetane-3, 2'-adamantane) disodium salt and exposed to x-ray film for 1-30 
minutes (Fig. 3 ). 
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Figure 3 The DNA-DNA "Checkerboard" membrane exposed to x-ray film. The 
rows on the left represent tooth numbers coded for specific LJP subjects (e.g. 
VDDU1 451 ). The columns at the top are labeled with tested microbe species 
e.g. (Pi, AY4) 
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VI. Periodontal Clinical Indices 
Periodontal clinical assessment was performed at baseline (n=10) and at 
24-months (n=9). The plaque index (Pl) and gingival index (GI) means were 
calculated for each subject based on 6 sites, mesial, mid, and distal on both the 
buccal and lingual surfaces. The probing depth (PD) and level of attachment (AL) 
were assessed with a University of North Carolina (UNC) probe to the nearest 
millimeter. 
I. Gingival Index (GI) 
The (GI) was determined using the Modified gingival index. We utilized a 
0-4 scoring system: 0 = absence of inflammation, 1 = mild inflammation, little 
change in texture of any portion of the papillary unit, 2 = mild inflammation, 
involving the entire marginal or papillary gingival unit, 3 = moderate inflammation: 
glazed redness, edema, and hypertrophy of the marginal or papillary gingival 
unit, 4 = severe inflammation, marked redness, edema, and/or hypertrophy of the 
marginal or papillary gingival unit, spontaneous bleeding, congestion or 
ulceration. 
11. The plaque index 
The plaque index (Pl) was determined using a modification of the Turesky-
Gilmore-Glickman modification of the Quigley-Hein plaque index. The focus was 
placed on the gingival 1/3 assessing the facial and lingual (dividing each side into 
distofacial, facial, and mesiofacial and lingual surfaces). We scored the surfaces 
using a disclosing agent (New 2 Tone, Lorvic Corp, St. Louis, MO). A plaque 
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score was determined as a percentage, by totaling all the plaque scores and 
dividing by the number of surfaces. 
Ill. The pocket depth (PD) 
The (PD) was measured as the depth the UNC probe was inserted parallel 
to the vertical axis and "walked" circumferentially. In our study, six measurements 
were taken; distofacial, facial, mesiofacial and the lingual surfaces. 
IV. Mobility (MOB) 
The (MOB) of the subjects' teeth was graded clinically by holding the tooth 
firmly between two blunt metallic handles (mirror) and an effort is made to move 
the tooth in all directions. The mobility of teeth was graded on a scale of 1-3. 1 = 
slight mobility of at least 1 mm, 1 += movement slightly more than 1 mm but < 
2mm, 2+:;; movement slightly more than 2mm but< 3mm, and 3= movement of at 
least 3mm. 
v. The Level of attachment (AL) 
The (AL) was measured as the distance between the base of the pocket 
and a fixed point, the cementa-enamel junction (CEJ). The gingival margin is 
located at the anatomic crown, and the depth of the pocket is subtracted from the 
distance between the gingival margin and the CEJ. If they were both the same, 
the loss of attachment was 0. The loss of attachment equaled the (PD) if the 
gingival margin coincides with the CEJ. 
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VI. Bleeding upon probing (BOP) 
The (BOP) in our study was determined as the UNC probe was inserted to 
the base of the pocket and gently moved laterally along the pocket wall, signs of 
bleeding were noted 30-60 seconds after probing. 
VII. Clinical Protocol 
LJP subjects received full mouth scaling and root-planing (S/RP) along 
with adjunctive antibiotic therapy where indicated. All subjects received S/RP, 
performed under local anesthesia, two (2) quadrants per visit. All four quadrants 
were completed within two weeks of initiation utilizing ultrasonic (cavitron) and 
hand scalers. LJP subjects were randomly assigned to either the antibiotic or the 
non-antibiotic groups. Five subjects were assigned to the non-antibiotic group 
., 
(subjects - #1 NB, #2KD, #3BG, #4BM, #7SS). Four subjects were assigned to 
the antibiotic group (subjects - #5WM, #6AR, #?HS, #9RT). Subject initials and 
trial numbers were used to preserve patient confidentiality. Antibiotic therapy 
was initiated concurrently with S/RP at a regimen of Amoxicillin 250mg and 
Metronidazole 250mg three times a day (t.i.d) for seven days. 
VIII. Surgical protocol 
The LJP subjects' clinical and radiographic profiles were thoroughly 
evaluated for affected areas before surgical therapy was initiated. The initial 
incision was reverse bevel along the gingival margin, to the crest of the bone on 
both the buccal and lingual sides. Full thickness mucoperiosteal flaps were 
elevated from the crest of the bone with maximum retention of the interdental 
papilla. Surgical treatment was Open Flap debridement, with the removal of 
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granulation tissue. The walls of the bony defect(s) were thoroughly root-planed, 
and the morphology noted, e.g. 1,2,3 wall defects. There was no use of osseous 
surgery, Guided Tissue Regeneration (GTR), or surgical dressing (Coe-Pak). 
Copious lavage was utilized when debriding the surgical site. The flaps were 
repositioned as close as possible to pre-surgical levels with interproximal 
interrupted 4-0 silk sutures (Look Corp, Norwell, MA). The patients were placed 
on chlorhexidine gluconate 0.12% (Peridex) prescription of½ oz two times daily 
(b.i.d) a.m. & p.m. for two (2) weeks. The sutures were removed seven (7) days 
after placement, and surgical sites were re-evaluated three weeks after surgical 
therapy. 
IX. Maintenance phase 
All the patients were recalled for periodic visits every third month. At 
these visits, oral hygiene (OH) instructions were reinforced and the patients 
underwent supragingival scaling (subgingival, if needed). The subjects' 
chemotactic and microbiological profiles were monitored at baseline and at the 
end of the trial period at 24-months. 
X. Statistical Analysis 
For each subject at each visit, and for each microbiological and clinical 
parameter, the per-subject average of the parameter was calculated across the 
measured tooth sites of the full-mouth. This "per-subject average" was used in 
all statistical analyses discussed below. 
For each group (non-antibiotic and antibiotic) and parameter, descriptive 
statistics (i.e., sample size, mean, standard deviation) of the per-subject average 
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was calculated at baseline and at 24 months. In addition, descriptive statistics of 
the per-subject average change from baseline to 24 months was calculated for 
each group and parameter. 
Within each group the significance of the change from base line to 24 
months was assessed for each parameter using the Signed Rank test. Within 
each group, comparisons on the change from baseline to 24 months between 
each microbiological parameter were performed using the Signed Rank test. 
Comparisons between groups on the change from baseline to 24 months were 
assessed using the Wilcoxon Rank sum test. 
47 
Results 
The sites treated by surgical therapy exhibited some post surgical recession, 
however, there was an overall increase in the clinical attachment level (AL) in 
both the antibiotic and non-antibiotic groups. Both groups demonstrated a 
decrease in pocket depth (PD), with the antibiotic group exhibiting the greater 
overall decrease. The plaque index (Pl) of the non-antibiotic group decreased 
more than its antibiotic counterpart. The gingival index (GI) of the non-antibiotic 
group decreased, whilst that of the antibiotic group remained unchanged. 
Inversely, there was an increase in the mobility (MOB) in the non-antibiotic group 
and no change in the antibiotic group. 
The baseline chemotaxis, microbiological, and periodontal clinical 
evaluations proceeded smoothly and without incident. The subjects were 
subsequently enrolled in the mechanical (S/RP) and chemotherapeutic phase of 
the trial, and all the patients received full mouth S/RP by quadrant prior to 
admission into the site specific surgical phase of the study. 
The surgical phase of the study proceeded without post-operative 
complications for all study subjects. There were no adverse events post-
surgically. All patients tolerated the surgical treatment well and post-operative 
symptoms were consistent with a site-specific periodontal surgical procedure. 
All the subjects were evaluated based on the study protocol; they were 
monitored for a twenty-four (24) month period. One dropout occurred in the 
antibiotic group. Chemotaxis and microbiologic profiles were re-evaluated at the 
end of the trial. Bacteriologic samples were taken at the sites that were treated, 
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at baseline and at study completion, for A.a. serotypes a and b, Porphyromonas 
gingivalis (P.g.) and Bacteriodes forsythus (B.f.). 
I. PMN Chemotaxis 
Examination of the neutrophil chemotaxis data, at baseline and at the 
completion of the trial, revealed that all of the (n=9) LJP patients, exhibited 
depressed PMN chemotaxis before and after periodontal therapy. The 
chemotactic response was evaluated with the Boyden chamber procedure, and 
peripheral PMN's were compared with age; sex; and race-matched controls, 
utilizing FMLP as the standard chemotractant. The results indicate that the 
chemotactic defect displayed by the nine subjects in our trial group is possibly 
due to a cell-associated defect of long and continuous duration. 
II. DNA-DNA "Checkerboard" microbiological analysis 
Examination of the microbiological data revealed that A.a. serotype b was 
the dominant microbe. Final 24-month evaluation (Fig.4) revealed A.a. 
predominated in both treatment groups, (mean A.a serotype b - 1.92 (antibiotic) 
and 1.67 (non-antibiotic). In the non-antibiotic group levels of both P.g. and B.f. 
were high at the final evaluation, whilst in the antibiotic groups they were 
significantly suppressed (P<0.10). Overall, we observed the following: (1) there 
was more suppression of microbes in the antibiotic group, (2) A.a. serotype a 
remained at low levels, (3) A comparison between the A.a. serotype a antibiotic 
and non-antibiotic groups demonstrated no statistical significance between 
groups, (4) We observed that significance does exist, between A.a. serotype b 
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Figure 4. A comparison between the antibiotic and non-antibiotic groups. The 
bar graph demonstrates the 4 species in the treatment groups. The graph 
represents the mean 24-month final evaluation profiles of all the subjects. A.a 
serotype b is the dominant microbe followed by B.f. (non-antibiotic group) and 
P .g. (non-antibiotic group). 
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and A.a. serotype a when mean levels were compared at the end of the 
treatment period. 
We found a significant difference between the presence of A.a. serotypes 
a and b overall. A.a. serotype b in both the antibiotic and the non-antibiotic 
treatment groups was present in significantly higher levels than both groups of 
A.a. serotype a (mean value of A.a. serotype b non-antibiotic: 1.92, and 
antibiotic: 1.67, A.a. serotype a was 0.679 and 0.675 respectively) (Fig. 5). 
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Figure 5. The A.a. serotype distribution, comparing serotype a and serotype b at 
the end of the 24- month period. A.a. serotype b predominates and is statistically 
significant. 
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Ill. Periodontal indices 
I. Pocket depth (PD) 
In comparing the mean 24-month data on periodontal indices, we found 
that the incremental decrease in the antibiotic group statistically significant 
compared to the non-antibiotic group. Mean decrease was 1.48mm (antibiotic) 
and 0.66mm (non-antibiotic). 
11. Attachment level (AL) 
The non-antibiotic patient group recorded a slightly higher increase in 
clinical attachment (AL). The non-antibiotic and antibiotic groups were 0.24mm 
and 0.23mm respectively. No clinical or statistical significance was evident. 
111. Bleeding upon probing (BOP) 
We observed relatively little change between the groups. The mean 
values were -0.012 (non-antibiotic) and 0.019 (antibiotic) respectively, 
representing a slight increase in the antibiotic group. There was no inter-group 
significance (Fig. 6). 
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Figure 6. The bar graph represents a comparison between periodontal indices 
measured after 24 months among LJP subjects in both the antibiotic and non-
antibiotic groups. Pocket depth (PD) of the antibiotic group is statistically 
significant. 
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We found subtle changes, between the groups when each group was 
evaluated on its own. Overall there was a decrease. The mean (Pl) of the non-
antibiotic group was significantly different from the antibiotic group. The mean 
values demonstrated a decrease · of 0.49 9 (non-antibiotic) and 0.03 (antibiotic) 
respectively. 
Gingival Index (GI) 
The only positive change was demonstrated in the non-antibiotic group 
(mean change 0.33). The antibiotic group was unchanged. 
Mobility (MOB) 
The mobility patterns observed between the groups were similar, with no 
change in the antibiotic group and a slight increase in the non-antibiotic treatment 
group. 
Intra-group comparison within the non-antibiotic group demonstrated a 
mean decrease in (PD) of 0.66mm and a gain in (AL) of 0.24mm. 
Inter-group comparison, demonstrates a statistically significant difference 
between the non-antibiotic group and the antibiotic groups in the (Pl) and (GI). 
We observed more positive change in the non-antibiotic group as opposed to the 
antibiotic group. Overall the mean periodontal indices of the antibiotic group 
demonstrated the greatest incremental gain in (PD) 1.48mm. There was also an 
increase in (AL) of 0.23mm. The other values remained relatively the same or 
with minimal or no significant change. 
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Discussion 
It was the purpose of this study to report on the efficacy of combination 
antimicrobial therapy in the treatment of LJP. The results demonstrate that the 
antibiotic group yielded a significant reduction in pocket depth. The remaining 
clinical indices from both groups demonstrated overall improvement, but no 
significant differences could be established. Overall, combination therapy was 
effective, however it was not possible too eliminate completely Actinobacillus 
actinomycetemcomitans (A.a.) from the study subjects. 
Both treatment groups, with and without antibiotics, resulted in reductions 
in probing depth (PD), attachment level (AL), bleeding on probing (BOP), plaque 
(Pl) and gingival (GI) indices, and mobility (MOB). No treatment group 
demonstrated improvements significantly more than the other, with the exception 
of (PD) in the antibiotic group. Comparisons, however, between other treatment 
studies of similar type or objective is difficult, due to variations in the drug 
concentrations, regimes, study length, patient sample size and periodontal 
surgical therapy. 
The present study demonstrates that in a group of nine LJP patients, there 
was a 100% exhibition of a PMN chemotaxis defect. Our study results are 
consistent with those demonstrated by other investigators, (Van Dyke et al. 1980) 
81 %, (Clark et al 1977) 7 of 9 LJP patients, and in 12 of 14 patients by Lavine et 
al 1979. Further studies are currently underway to determine the etiology of the 
defect. The results observed in our study demonstrate that the PMN defect 
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persisted throughout the entire trial period. Van Dyke et al. (1980) suggested 
that this observed defect is due to a cell-associated defect of long duration and 
that the PMN plays a protective role against periodontal infection, with the 
cellular chemotactic response possibly providing a predisposition to LJP. Our 
observations are consistent with the above mentioned studies. The data points 
to a more cellular as opposed to an acquired predisposition, indicative of an even 
more aggressive nature of the "defect", because it is resistantto conventional, 
therapeutic and surgical therapy. 
A critical observation we made was that A.a. serotype b was the dominant 
strain of (A.a.) in our trial population from baseline to the 24-month study 
completion. This study confirms and extends the previous data presented by 
(Zambon et al. 1983), (McArthur et al. 1981) and (McArthur et al 1986). Zambon 
et al. (1983) (2), demonstrates the presence of A.a. serotype bin 6 of 9 patients. 
In a subsequent paper the same author observed the incidence of serotype b to 
be 2x higher in serotype a or c in 29 LJP patients. This data, in accordance with 
the observations from our study, is highly suggestive of a pathogenic role of A.a. 
serotype bin the etiology of LJP. Study data results; also probably suggest that 
the disease pathogenicity be linked to leukotoxins more frequently associated 
with the 'b' serotype. 
Evaluation of the clinical results and the resultant data, with other 
antibiotic trials is initially difficult due to the variations in antibiotic regimes. In 
recent studies on the treatment of LJP employing systemic antibiotic therapy, can 
be subdivided into the Tetracycline's: tetracycline (TCN), and doxycycline (DOX), 
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Metronidaziole (MET), Penicillin (PEN) and combination therapy such as (MET) 
and amoxicillin (AMOX). 
In our study we utilized combination therapy. The drugs of choice were, 
metronidazole and amoxicillin. The study protocol called for both drugs at the 
250mg level. van Winkelhoff et al. 1989 and 1992 used MET 250 mg and AMOX 
375 mg (t.i.d) for seven days. The authors in the 1989 paper eliminated A.a. in 
all patients and improved clinical parameters. In their1992 study they eliminated 
A.a. in 97% and P.g. in 88% of 28 LJP subjects. 
The rationale for the use of these drugs has been based on the 
experiments of Pavicic et al. (1991 ), the investigators demonstrated that these 
antibiotics act synergistically 'in vitro' with a fractional bacterial index (FBCI) of 
0.4-0.6. Pavicic suggests the decrease in anaerobic J3-lactamase producing 
microbes as enhancing the effect of the aminopenicillin. 
The results of our study demonstrate a 100% presence of A.a. in subjects 
at base line and at study completion. The data in this present study is closer to 
that presented by Tinoco et al. (1998) on Brazilian adolescents. The 
aforementioned group utilized MET 750 mg and AMOX 1500mg daily for eight 
days. They treated two LJP groups: an experimental group - mechanical 
treatmenUdrug combination, and a control group - mechanical treatment/ 
placebo. Tinoco et al. (1998) reported A.a. in the control group to be detectable 
at 100% levels at baseline and at the end, whilst the experimental groups 
showed a decrease by 50% from baseline to study completion. 
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Possible explanations for the high concentrations of A.a. detected at the 
end of our study, in comparison to the work of other groups, may be as a result of 
the lower concentrations of drug and a longer re-evaluation period. It is possible 
that the regimes utilized by van Winkelhoff and Tinoco were in excess of the 
minimum inhibitory concentrations. Clinical re-evaluations in our study were 
carried out at the end of a two-year period. Tinoco et al. (1998) concluded study 
evaluations at the end of one year, (van Winkelhoff et al. 1992) at three (3) to 
nine (9) months with a mean of 4.9 ± 2.0 months. 
The van Winkelhoff et al. (1989), study utilized combination antibiotic 
therapy as a adjunct to S/RP, and reports post-treatment levels of A.a. as being 
suppressed below detectable levels in all patients except one. A.a. was present 
in all patients prior to treatment and not detected at the 2 to 4 month and the 9 to 
11 month evaluations. It is quite possible that if our data were analyzed earlier or 
theirs later, similarities may have been present. 
The treatment outcomes of clinical studies employing antibiotic therapies 
in LJP patients have consistently been positive. The tetracyclines, although their 
current use has decreased in popularity as a treatment modality for LJP, have 
been utilized with moderate success in the past. Christersson and Zambon 
(1993), n=6 utilized TCN 250mg for one (1) week after A.a. was undetectable or 
for a maximum of eight (8) weeks. The authors noted an improvement in clinical 
parameters. 
Our study demonstrates some similarity with the Christersson and 
Zambon (1993) study,' in that they used a 24-month follow up and A.a. was 
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detectable at the end of the trial period in 4 to 6 subjects. Lindhe 1981, also 
employed TCN 250mg (q.i.d) for 14 days. Similarly to our study, he also used 
surgical therapy as concurrent treatment. Unlike our study, the Lindhe group 
were able to detect recurrent disease activity in 25% of the n=16 patients in 24 
months. 
These studies, although like our trial use 24 months as the follow up time 
· and have improvements in clinical parameters, comparisons are difficult to make 
with our study. Lindhe utilizes surgical therapy, whilst the Christerrson and 
Zambon group do not. The length of use of antibiotic therapy exceeds ours in 
the case of the latter group, who persists with antibiotics for up to 8 weeks in 
specific cases. Nevertheless all the groups did recognize improvements in 
clinical parameters during the trial period. 
In amoxicillin and metronidazole studies the (PD) has consistently been 
reduced. Pavicic et al. (1994 ), in a clinical trial recorded a reduction in (PD) in 
both antibiotic and the non-antibiotic groups. van Winkelhoff et al. (1989) in a 
investigation involving 11 LJP subjects, reports (PD) reductions of 1.5mm in the 
group of patients with a history of prior dental treatment, and 1.9mm reduction in 
the absence of treatment. van Winkelhoff et al. (1992); subsequently report a 
decrease in pocket depth of 2.2mm at treatment end. Tinoco et al. (1998) sites 
probing reductions, for the experimental and control groups as 3.0mm and 
2.5mm, respectively. Novak et al. (1991) utilizing TCN 250mg (q.i.d) for 42 days 
in 4 LJP patients in the absence of other therapies, reduced (PD) for up to four 
(4) years. 
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The results of our clinical study are more comparable with that of van 
Winkelhoff et al. (1989), with (PD) reductions of 1.5mm. The mean probing 
depth reduction that was noted in our population was 1.48mm (antibiotic) and 
0.66mm (non-antibiotic). One possible explanation for this could be the 
eradication of A.a. from the deep pocket epithelium leading to a decrease of 
inflammatory infiltrate, subsequent tissue shrinkage and decrease in gingival 
inflammation. Henceforth, the use of antibiotic therapy in the treatment of LJP 
can be considered justifiable, based on its ability to alter the pathogenic 
microflora, with a resultant decrease in pocket depth. 
Attachment levels (AL) for this study were less favorable than those 
reported by other investigators, the antibiotic and non-antibiotic groups report 
(AL) gains of 0.23mm and 0.244mm respectively. van Winkelhoff et al. (1992) 
records a significant (AL) gain of 1.3mm. Tinoco et al. (1998) sites both (AL) 
gains and losses. (AL) gains in the experimental and control groups were 2.9mm 
and 2.6mmrespectively, and losses 1.6mm and 2.2mm respectively. Novak et al. 
(1991) utilizing (TCN) 250 mg (q.i.d) for 42 days reduced (AL) for up to 4 years, 
whilst (Slots and Rosling 1983), using the same regime for 14 days were also 
able to reduce (AL). 
The reductions made by Novak et al. (1991) and Slots and Rosling (1983), 
are of limited comparison, due to the difference in antibiotic regimen. In our 
study, there were no significant differences between the treatment groups 
antibiotic and non-antibiotic. One possible explanation for the low gains in 
clinical attachment level in comparison to the other studies may have been· due 
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to our use of site-specific surgical therapy in all nine (9) subjects. All sites 
amenable to surgical therapy were treated in our study, and while post -surgical 
recession was low, it may have been a factor. van Winkelhoff et al. (1992) 
initiated surgical treatment only in selected cases and Tinoco et al. (1998) did not 
utilize surgery as a treatment modality. 
The plaque index (Pl) decreased throughout our study, mean (Pl) 
decrease in the non-antibiotic group was 0.4 and in the antibiotic group 0.03. 
Tinoco et al. (1998), demonstrated decreases in (Pl) for the experimental group 
and control group at 0.8 and 0.5 respectively. There was no significant 
difference between the antibiotic and non-antibiotic groups in our study. It is 
possible that the evaluation period of 24 months, as opposed to 12 months in the 
Tinoco study, may explain the lower (Pl) values of our study. The overall plaque 
control for the clinical trial subjects was very good. The Hawthorn effect may 
have played a role, as the patients were given (OH) reinforcement every 3 -
months. 
The gingival index (GI) in the Tinoco group was very similar to the 
numbers in this study. The experimental group demonstrates improvement with 
a mean of 0.3; the control group records a higher post-treatment mean of 0.1. In 
our study the non-antibiotic group demonstrated similar mean improvement of 
0.33, while in the antibiotic group no improvement was observed. 
There was no statistically significant change in mobility (MOB) measures, 
of the treated teeth during the duration of the study. A possible explanation for 
this could be the return to pre-treatment levels of mobility, one year post-surgery 
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as described by Kerry et al. (1982). Therefore, initial and final mobility 
measurements would register no significant change. 
The results of this study display that there are limitations of sample size, 
and the absence of a negative control. A larger sample size (at least 20 patients) 
and with a negative control (antibiotic therapy as the only treatment), may have 
yielded a difference between trial groups. 
Analysis of the study data demonstrates that both treatment groups (with 
and without adjunctive antibiotic treatment) yielded positive results overall. The 
overall treatment outcome in the antibiotic group is better, as displayed by the 
significant decrease in pocket depth. The limited improvement in attachment 
levels in both study groups, is possibly a result of post-surgical recession. 
Nevertheless, the trend towards greater improvement in the antibiotic group 
suggests that judicious use of antibiotic therapy can provide clinical improvement 
in LJP patients. 
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